CBIO
CRESCENT BIOPHARMA, INC.
-0.30 (-1.78%)16.88USD188K成交股數627M市值–本益比(近四季)52.8股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00 | 1.0M | – | – | 0.00 | 0.00 | 0.00 | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 19.4M | 17.9M | – | 20.3M | 12.1M | 10.6M | 14.0M | 2.5M | 6.3M | 6.0M | 5.3M | 5.3M |
| 銷售管理費用 | 8.7M | 7.9M | – | 5.5M | 8.9M | 3.6M | 3.2M | 158K | 4.1M | 5.1M | 4.3M | 4.5M |
| 營業利益 | −26.4M+25% | −24.7M+74% | – | −25.9M+884% | −21.0M+103% | −14.2M+28% | −17.2M+79% | −2.6M-73% | −10.4M | −11.1M | −9.6M | −9.8M |
| 營業利益率 | – | -2,380.1% | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −24.8M+14% | −23.3M+54% | −23.3M+30% | −24.6M+835% | −21.8M+116% | −15.1M+41% | −17.9M-164% | −2.6M-71% | −10.1M | −10.7M | 27.9M | −9.2M |
| 淨利率 | – | -2,240.9% | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | -0.15+7% | -0.16 | -0.04 | -0.14 | -0.14 |
| 稀釋股數 | – | – | – | – | – | – | – | 64.5M | 64.5M | 64.5M | 63.3M | 64.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 172M | 189M | 213M | 133M | 153M | 22.4M | 34.8M | 14.4M | 22.4M | 31.3M | 41.8M | 49.4M |
| 應收帳款 | 0.00 | 0.00 | 18.0M | – | – | – | 0.00 | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 183M | 199M | 240M | 138M | 157M | 6.0M | 35.6M | 15.7M | 24.4M | 34.2M | 45.3M | 53.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 19.5M | 15.3M | 37.3M | 21.6M | 18.2M | 2.6M | 47.1M | 4.3M | 4.4M | 5.3M | 6.9M | 6.7M |
| 股東權益 | 163M | 184M | 203M | 117M | 139M | −30.2M | −15.5M | −1.3M | 20.1M | 28.9M | 38.4M | 46.5M |
| 負債比 | 10.7% | 7.7% | 15.5% | 15.6% | 11.5% | 43.7% | 132.2% | 27.5% | 17.8% | 15.5% | 15.2% | 12.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.9M-18% | – | – | – | −10.9M+3% | −6.3M | 0.00 | – | −10.5M | – | – |
| 資本支出 | – | 147K | – | – | – | 0.00 | 0.00 | 0.00 | – | 7K | – | – |
| 自由現金流 | – | −9.1M-16% | – | – | – | −10.9M+3% | −6.3M | 0.00 | – | −10.5M | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -874.3% | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 10.8M
| Reportable | 10.8M | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 10.8M | – | 154K | 1.4% | – | −72.5M |
| FY2024 | – | – | 38K | –% | -0.59 | −31.1M |
| FY2023 | 10K | -86.7% | 37K | 369.0% | -0.58 | −34.9M |
| FY2022 | 75K | -93.5% | −46.7M | -62,251.7% | -0.89 | −46.5M |
| FY2021 | 1.2M | -88.6% | −63.4M | -5,469.0% | -1.23 | −57.5M |
| FY2020 | 10.2M | – | −51.0M | -502.1% | -1.12 | −39.3M |
| FY2019 | – | – | −57.9M | –% | -1.34 | −52.1M |
| FY2018 | – | – | −48.3M | –% | -1.18 | −43.5M |